Gc Biopharma USA, Inc.

NJ · United States · Reporting entity ID 100001450392

Total reported 2019–2025

$107K

#2,130 of 2,960 reporting companies — 0% of all reported industry payments

$72K in general payments across 879 records, plus $34K in research funding across 1 records.

How it breaks down

General payments $72,154

Research funding $34,430

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.